“Pediatric Clinical Trial Program in Progress: A Phase 3 Study and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 Years of Age With Severe Alopecia Areata”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s768. Accessed April 30, 2026. https://skin.dermsquared.com/skin/article/view/4047.